Screeners
Heatmaps
Trends
News

You're viewing limited data.

Sign up

1 asset

Market news

TypeAll

SortNewest

Assets

APRE

Type

TypeAll

All

Sort

SortNewest

Newest

Filter by asset

Aprea Therapeutics to present WEE1 inhibitor trial data in November

Sep 22Investing.com

Aprea Therapeutics at H.C. Wainwright conference: early data lifts outlook

Sep 14Investing.com

Aprea Therapeutics reports patent portfolio of 58 patents

Aug 28Investing.com

Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs

Company Strengthens Global Intellectual Property Portfolio with 28 Issued and 30 Pending Patents

Aug 28Barchart.com

Aprea Therapeutics records second consecutive surge, jumping another 22% (APRE:NASDAQ)

Aug 25Seeking Alpha

Lipocine Appoints Michael J. Grissinger to Board of Directors

Aug 3Yahoo Finance

Aprea Therapeutics plans Q4 2026 data update for APR-1051 trial

Jul 30Investing.com

This is the newest page. Registered accounts read further back.